Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China flag China · Delayed Price · Currency is CNY
10.15
+0.13 (1.30%)
At close: Mar 30, 2026

SHE:002873 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
173.72118.16138.24100.6772.48
Trading Asset Securities
0.10.120.090.1180
Cash & Short-Term Investments
173.82118.28138.33100.78152.48
Cash Growth
46.95%-14.49%37.26%-33.91%-65.97%
Accounts Receivable
286.84325.67250.54261.96282.72
Other Receivables
8.1322.0948.2242.1221.52
Receivables
294.97347.77298.76304.08304.24
Inventory
172.11145.48184.33183.34118.77
Other Current Assets
10.145.281522.4411.34
Total Current Assets
651.04616.81636.43610.65586.83
Property, Plant & Equipment
693.38708.83706.3593.75463.94
Long-Term Investments
530.34412.07383.27461.57312.5
Goodwill
6.19----
Other Intangible Assets
108.62108.9683.5286.187.51
Long-Term Deferred Tax Assets
9.0310.0610.3313.4611.26
Long-Term Deferred Charges
102.1190.3688.4570.3958.67
Other Long-Term Assets
20.373.413.53.63.71
Total Assets
2,1211,9511,9121,8401,524
Accounts Payable
68.5983.36105.0895.6764.89
Accrued Expenses
29.7148.9131.839.7153.85
Short-Term Debt
95.88306.24366.93317.37268.34
Current Portion of Long-Term Debt
146.7720.826.035.01-
Current Portion of Leases
-4.974.161.4-
Current Income Taxes Payable
13.650.0302.294.72
Current Unearned Revenue
0.370.52113.8615.36
Other Current Liabilities
25.2316.5520.4226.434.07
Total Current Liabilities
380.2481.38555.42501.69441.23
Long-Term Debt
420.77221.4195.54156.68154.79
Long-Term Leases
5.486.779.355.726.65
Long-Term Unearned Revenue
24.2723.5820.8322.1524.51
Long-Term Deferred Tax Liabilities
33.5922.1116.7227.993.38
Other Long-Term Liabilities
0.520.550.593.363.42
Total Liabilities
864.83755.79798.47717.59633.98
Common Stock
244.1244.1231.49231.97164.05
Additional Paid-In Capital
282.35282.35179.72187220.67
Retained Earnings
660.32665.32637.57579.88490.94
Treasury Stock
-75.3-75.3-9.54-17.61-27.81
Comprehensive Income & Other
144.7778.2474.09140.6942.61
Total Common Equity
1,2561,1951,1131,122890.44
Shareholders' Equity
1,2561,1951,1131,122890.44
Total Liabilities & Equity
2,1211,9511,9121,8401,524
Total Debt
668.9560.18602.01486.17429.79
Net Cash (Debt)
-495.09-441.9-463.68-385.39-277.31
Net Cash Per Share
-2.10-2.01-1.90-1.58-1.13
Filing Date Shares Outstanding
209.59235.3231.4231.89228.31
Total Common Shares Outstanding
209.59235.3231.4231.89228.31
Working Capital
270.84135.4381108.96145.59
Book Value Per Share
5.995.084.814.843.90
Tangible Book Value
1,1411,0861,0301,036802.93
Tangible Book Value Per Share
5.454.614.454.473.52
Buildings
-628.65639.78369.03327.11
Machinery
-177.35167.14121.4792.52
Construction In Progress
-55.8133.72228.36151.22
Source: S&P Global Market Intelligence. Standard template. Financial Sources.